Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wilsozyme
- Development stage
- Unknown
- Lead developer
- Wilson Drugs & Pharmaceuticals
- Administration
- Oral
01
Overview
Wilsozyme is an Ayurvedic patent medicine developed by Wilson Drugs & Pharmaceuticals. It is formulated as a multi-herb mixture containing traditional Ayurvedic ingredients such as ginger (Zingiber officinale), black pepper (Piper nigrum), long pepper (Piper longum), liquorice (Glycyrrhiza glabra), papaya (Carica papaya), and Embelia ribes. Available in tablet, capsule, and syrup formulations, Wilsozyme is indicated for the treatment of gastrointestinal issues including indigestion, anorexia, loss of intestinal flora, bloating, and other intestinal troubles. It works by stimulating appetite, improving digestion, and supporting overall gut health.
- Brand names
- Wilsozyme CapsuleWilsozyme SyrupWilsozyme Tablets
Beyond the preview
Go deeper on Wilsozyme.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wilsozyme.